๐บ The recording of Episode 5 of the #ESHG Webinar Series "From Chromatinopathies to Episignatures" by Siddharth Banka (Manchester Rare Conditions Centre,
@mft-imrare.bsky.social) is now on YouTube! Watch here: youtu.be/GMgWiGXq6mc?...
@eshg.bsky.social
The ESHG is a non-profit organization. Its aims are to promote research in basic and applied human and medical genetics, to ensure high standards in clinical practice and to facilitate contacts between all persons who share these aims.
๐บ The recording of Episode 5 of the #ESHG Webinar Series "From Chromatinopathies to Episignatures" by Siddharth Banka (Manchester Rare Conditions Centre,
@mft-imrare.bsky.social) is now on YouTube! Watch here: youtu.be/GMgWiGXq6mc?...
๐ New in Nature: Long-read sequencing of 1019 genomes reveals structural variant (SV) diversity across 26 human populations, providing a global resource for understanding genetic variation and its link to human disease.
#Genomics #Pangenome #SVs
www.nature.com/articles/s41...
๐งฌMultiplexed Assays of Variant Effect (MAVEs) generate functional data for thousands of variants in a single experiment, accelerating VUS reclassification and improving patient care.
#MAVEs #Genomics
Explore the latest advances in MAVE technologies:
www.nature.com/articles/s41...
Genetic and genomic knowledge is key in todayโs clinical practice.
Explore 3 free, online courses on the ESHG Xpeer Channel - covering rare diseases, hereditary cancer, and prenatal screening.
๐ Start learning now: buff.ly/GciCCGE
#Genetics #Genomics #MedicalEducation #Xpeer #ESHG
๐ข Episode 5 of the #ESHG Webinar Series is on Wednesday, July 30 at 16:00 CEST!
๐งฌ Speaker: Siddharth Banka: "From Chromatinopathies to Episignatures"
๐ป Registration is free but required: wma.eventsair.com/eshg-webinar...
๐ฉ Past registrants will receive the Zoom link automatically.
New in @ejhg-journal.bsky.social ๐ข
Comprehensive phenotypic and genotypic characterization of CNOT3-related neurodevelopmental disorders #NDDs:
๐งฌ 51 patients from 42 families
๐ 28 novel variants
๐ Missense variants clustered in key functional domains
www.nature.com/articles/s41...
ESHG welcomes forthcoming consultations on Greek newborn screening programme. On this topic, the EJHG has opened a call for papers on the use of genetic data in public health screening programmes. Read the full ESHG statement here: tinyurl.com/m8bp6m4m
16.07.2025 15:45 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0@ejhg-journal.bsky.social is now actively sharing updates, publications, and announcements on Bluesky.
If you havenโt connected with them yet, weโd love to invite you to follow the account.
๐A semi-automated mtDNA-filtering pipeline combined with MitoPhen-based HPO phenotype similarity scoring was applied to a large cohort of undiagnosed rare disease patients, increasing the diagnostic yield by 0.4%.
#SolveRD #mtDNA #RareDisease
Read more:
www.cell.com/ajhg/fulltex...
Today, the Scientific Programme Committee wrapped a fantastic and exciting programme for #eshg2026 conference! More information will available on our conference website soon. We look forward to welcoming you in Gothenburg!
27.06.2025 11:00 โ ๐ 13 ๐ 5 ๐ฌ 0 ๐ 2Episode 4 of the ESHG Webinar Series is now available on YouTube!
Kaitlin Samocha discusses how population data can improve variant interpretation, with a focus on rare disease.
๐บ Watch the recording: youtu.be/pWhienkM6L4?...
#Genomics #RareDisease #VariantInterpretation #ESHG
Introducing Eye2Gene: a deep-learning model trained on multimodal retinal imaging (FAF, IR, OCT) to predict causative genes among 63 candidates for inherited retinal diseases, supporting diagnosis and variant prioritization.
๐ app.eye2gene.com
www.nature.com/articles/s42...
๐ข Episode 4 of the #eshg Webinar Series is on June 25 at 16:00 CEST!
๐งฌ Speaker: Kaitlin Samocha on variant interpretation using population data
๐ป Registration is free but mandatory: wma.eventsair.com/eshg-webinar...
๐ฉ Past registrants will receive the Zoom link automatically.
The Greek governmentโs decision to delegate newborn screening to private organisations without prior public consultation raises concerns about transparency and ethical oversight. Read the full ESHG statement for details: www.eshg.org/news-home/fo... #NewbornScreening #PublicHealth #eshg
12.06.2025 13:58 โ ๐ 1 ๐ 2 ๐ฌ 0 ๐ 0๐ AI is reshaping clinical genetics! This latest review by Duong & Solomon outlines how machine learning, deep learning, and generative AI are transforming diagnostics, management, lab workflows, and administrative processes
๐ Open-access review๐
www.nature.com/articles/s41...
Still thinking about #eshg2025. Browse through the most vibrant moments of the conference in our photo gallery: www.flickr.com/photos/19719...
12.06.2025 12:36 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0The ESHG Education Committee is seeking new members!
๐Join us in shaping the future of genomics education through mentorship, collaboration, and high-quality training initiatives.
Application deadline: July 20, 2025
Start date: September 1, 2025
Apply: www.eshg.org/educom
๐ขOut in @ejhg-journal.bsky.socialโฌ
Bi-allelic inactivating variants in ZNF142 are associated with a specific DNA methylation signature. This robust signature offers a promising epi-diagnostic tool for ZNF142 neurodevelopmental cases.
#NDDs #DNAm #Episignature
www.nature.com/articles/s41...
๐ง New Insights on reproductive and cognitive phenotypes in carriers of recessive pathogenic variants.
This research highlights how even being a carrier of variants in genes associated with ID may impact cognitive development and academic outcomes.
www.nature.com/articles/s41...
#CognitiveScience
New research investigates de novo variants in R-loop forming regions across large-scale genomic datasets identifying RNU2-2 and RNU5B-1 as novel #NDDs genes. Together with RNU4-2, these explain a high number of previously unsolved NDDs cases.
#snRNAs
www.nature.com/articles/s41...
#eshg2025 itโs a wrap! We hope you enjoyed this yearโs #eshg #hybridconference. Thank you for being part of it! We look forward to seeing you all at #eshg2026 in Gothenburg!
27.05.2025 14:04 โ ๐ 31 ๐ 7 ๐ฌ 0 ๐ 0Since 2018, the European Society of Human Genetics has been presenting the ELPAG Award. It is presented to honour a scientist having made an important mark in the field of Ethical, Legal and Psychosocial Aspects of Genetics.
#ESHG2025 ELPAG Award laureate:
Sylvia Metcalfe (Melbourne, Australia)
DNA Day 2025 - Essay Contest
1st Place: Snigdha Rai (IN)
2nd Place: Mei Bejdo (AL)
3rd Place: Basak Memiguven (TR)
ESHG DNA Day 2025 - Video Contest
1st Place: Tanush Gupta (UK)
1st Place: Dakyung Yoon (KR)
3rd Place: Jaime Chan (UK)
#ESHG2025
ESHG Observership scheme awardees 2025
โข Purvi Majethia India to Manchester, UK
โข Luiza Lorena Pires Ramos Belgium to Stockholm, Sweden
โข Juliana Miranda Cerqueira Finland to Cambridge, UK
โข Vanessa Sousa Portugal to Leuven, Belgium
โข Sรญlvia Pires Portugal to Jena, Germany
#ESHG2025
Tune in at 15:25 CEST to meet this yearโs winners of the Gert Jan Van Ommen Citation Awards presented by EJHG Journal, the Early Career Award Winners, the Dian Donnai & Jill Clayton-Smith Award Winners and the #eshg DNA Day Winners 2025!
27.05.2025 13:15 โ ๐ 4 ๐ 2 ๐ฌ 0 ๐ 0ESHG Mentorship scheme awardees 2025
โข Nesibe Bulut Turkey to Vienna, Austria
โข Tea Mladeniฤ Croatia to Jena, Germany
โข Melda Erdoฤdu Turkey to Linkรถping, Sweden
โข Lein Dofash Australia to Exeter, UK
โข Daniela Oliveira Portugal to Stockholm, Sweden
#ESHG2025
#ESHG2025 Dian Donnai and Jill Clayton-Smith Prize for Dysmorphology 2025
Winner: Emre Akbas, Eskisehir, Turkey
SHG2025 ELPAG Early Career Award
for the best presentation on Ethical, Legal and Psychosocial Aspects of Genetics
Tara Maria Hoffmann, Hamburg, Germany
"Identity Crisis and Emotional Strain in Parents of Children with Rare and Undiagnosed Conditions: A Qualitative Study"
#ESHG2025 Mia Neri Award
for best presentation in cancer research.
Jingzhan Lu,Exeter, United Kingdom
"Predicting prostate cancer by combining Prostate Specific Antigen (PSA) test results with Genetic Risk Scores (GRS)"
#ESHG2025 Vienna Medical Academy Award:
Best presentation in translational genetic reserach/therapy of genetic diseases.
Christina Marie Kajba, London, UK
"A pooled prime editing platform in haploid human cells for high throughput variant screening"